[go: up one dir, main page]

ATE307570T1 - Partikel zur inhalation - Google Patents

Partikel zur inhalation

Info

Publication number
ATE307570T1
ATE307570T1 AT00988840T AT00988840T ATE307570T1 AT E307570 T1 ATE307570 T1 AT E307570T1 AT 00988840 T AT00988840 T AT 00988840T AT 00988840 T AT00988840 T AT 00988840T AT E307570 T1 ATE307570 T1 AT E307570T1
Authority
AT
Austria
Prior art keywords
particles
inhalation
droplets
carrier gas
liquid feed
Prior art date
Application number
AT00988840T
Other languages
English (en)
Inventor
Wiwik Watanabe
Petri Ahonen
Esko Kauppinen
Raoul Jaervinen
David Brown
Jorma Jokiniemi
Esa Muttonen
Original Assignee
Orion Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=67253261&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE307570(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Orion Corp filed Critical Orion Corp
Application granted granted Critical
Publication of ATE307570T1 publication Critical patent/ATE307570T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J2/00—Processes or devices for granulating materials, e.g. fertilisers in general; Rendering particulate materials free flowing in general, e.g. making them hydrophobic
    • B01J2/02—Processes or devices for granulating materials, e.g. fertilisers in general; Rendering particulate materials free flowing in general, e.g. making them hydrophobic by dividing the liquid material into drops, e.g. by spraying, and solidifying the drops
    • B01J2/04—Processes or devices for granulating materials, e.g. fertilisers in general; Rendering particulate materials free flowing in general, e.g. making them hydrophobic by dividing the liquid material into drops, e.g. by spraying, and solidifying the drops in a gaseous medium

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Pulmonology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Otolaryngology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Manufacturing Of Micro-Capsules (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Saccharide Compounds (AREA)
  • Steroid Compounds (AREA)
AT00988840T 1999-12-30 2000-12-28 Partikel zur inhalation ATE307570T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FI19992820 1999-12-30
FI20002217A FI20002217L (fi) 1999-12-30 2000-10-06 Inhalaatiopartikkelit
PCT/FI2000/001151 WO2001049263A1 (en) 1999-12-30 2000-12-28 Inhalation particles

Publications (1)

Publication Number Publication Date
ATE307570T1 true ATE307570T1 (de) 2005-11-15

Family

ID=67253261

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00988840T ATE307570T1 (de) 1999-12-30 2000-12-28 Partikel zur inhalation

Country Status (10)

Country Link
US (1) US20040081626A1 (de)
EP (1) EP1242048B2 (de)
JP (1) JP5139615B2 (de)
AT (1) ATE307570T1 (de)
AU (1) AU2519701A (de)
CA (1) CA2395881C (de)
DE (1) DE60023547T3 (de)
ES (1) ES2251418T5 (de)
FI (1) FI20002217L (de)
WO (1) WO2001049263A1 (de)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0811279B2 (ja) 1990-04-23 1996-02-07 吉則 片平 ダイカスト鋳造方法
US7575761B2 (en) 2000-06-30 2009-08-18 Novartis Pharma Ag Spray drying process control of drying kinetics
FI20002216A0 (fi) * 2000-10-06 2000-10-06 Orion Yhtymae Oyj Yhdistelmäpartikkelit astman hoitoon
FI20002215A0 (fi) 2000-10-06 2000-10-06 Orion Yhtymae Oyj Yhdistelmäpartikkelit
FI20011386A0 (fi) * 2001-06-28 2001-06-28 Orion Corp Inhalaatiopartikkeleja
JP2005514188A (ja) * 2001-12-07 2005-05-19 エイフェル テクノロジーズ リミテッド 小粒子の合成
US9808471B2 (en) * 2003-04-16 2017-11-07 Mylan Specialty Lp Nasal pharmaceutical formulations and methods of using the same
US8912174B2 (en) * 2003-04-16 2014-12-16 Mylan Pharmaceuticals Inc. Formulations and methods for treating rhinosinusitis
US7811606B2 (en) * 2003-04-16 2010-10-12 Dey, L.P. Nasal pharmaceutical formulations and methods of using the same
US20060009435A1 (en) * 2004-06-23 2006-01-12 Joseph Kaspi Synthesis and powder preparation of fluticasone propionate
GB0425758D0 (en) 2004-11-23 2004-12-22 Vectura Ltd Preparation of pharmaceutical compositions
CA2869849A1 (en) 2012-04-13 2013-10-17 Glaxosmithkline Intellectual Property Development Limited Aggregate particles comprising nanoparticulate drug particles of umeclidinium bromide, vilanterol trifenatate and fluticasone furoate
US20140147475A1 (en) 2012-11-29 2014-05-29 Antonius Arnoldus Christiaan Jacobs Vaccine to protect a ruminant against pneumonia caused by pasteurella multocida
AU2014234452B2 (en) * 2013-03-18 2018-02-22 Intervet International B.V. Vaccine to protect a ruminant against pneumonia caused by Mannheimia haemolytica

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3306250A1 (de) * 1983-02-23 1984-08-23 Basf Ag, 6700 Ludwigshafen Sphaerische einkristalle fuer pharmazeutische zwecke
FR2624505A1 (fr) * 1987-12-11 1989-06-16 Rhone Poulenc Chimie Zircone stabilisee, son procede de preparation et son application dans des compositions ceramiques
GB8828477D0 (en) * 1988-12-06 1989-01-05 Riker Laboratories Inc Medical aerosol formulations
US5061682A (en) * 1990-01-17 1991-10-29 The Washington Technology Center Ceramic precursor mixture and technique for converting the same to ceramic
GB9105705D0 (en) * 1991-03-18 1991-05-01 Sandoz Ltd Improvements in or relating to organic compounds
US6060069A (en) * 1991-05-20 2000-05-09 Dura Pharmaceuticals, Inc. Pulmonary delivery of pharmaceuticals
US6582728B1 (en) * 1992-07-08 2003-06-24 Inhale Therapeutic Systems, Inc. Spray drying of macromolecules to produce inhaleable dry powders
US5819726A (en) * 1993-01-29 1998-10-13 Aradigm Corporation Method for the delivery of aerosolized drugs to the lung for the treatment of respiratory disease
KR100419037B1 (ko) * 1994-03-07 2004-06-12 넥타르 테라퓨틱스 폐를통한인슐린의전달방법및그조성물
US6019968A (en) * 1995-04-14 2000-02-01 Inhale Therapeutic Systems, Inc. Dispersible antibody compositions and methods for their preparation and use
US5972331A (en) * 1995-12-22 1999-10-26 Schering Corporation Crystalline interferon alpha for pulmonary delivery and method for producing the same
US5855913A (en) * 1997-01-16 1999-01-05 Massachusetts Instite Of Technology Particles incorporating surfactants for pulmonary drug delivery
EP0954282B1 (de) * 1997-01-16 2005-01-19 Massachusetts Institute Of Technology Zubereitung von partikelhaltigen arzneimitteln zur inhalation
US6338809B1 (en) * 1997-02-24 2002-01-15 Superior Micropowders Llc Aerosol method and apparatus, particulate products, and electronic devices made therefrom
US7625420B1 (en) * 1997-02-24 2009-12-01 Cabot Corporation Copper powders methods for producing powders and devices fabricated from same
US6051257A (en) * 1997-02-24 2000-04-18 Superior Micropowders, Llc Powder batch of pharmaceutically-active particles and methods for making same
AU780327B2 (en) * 1999-06-30 2005-03-17 Novartis Ag Spray drying process for preparing dry powders

Also Published As

Publication number Publication date
EP1242048B2 (de) 2019-01-23
JP2003519171A (ja) 2003-06-17
EP1242048B1 (de) 2005-10-26
DE60023547T2 (de) 2006-07-27
CA2395881A1 (en) 2001-07-12
US20040081626A1 (en) 2004-04-29
WO2001049263A1 (en) 2001-07-12
CA2395881C (en) 2009-02-03
ES2251418T3 (es) 2006-05-01
FI20002217A7 (fi) 2001-07-01
AU2519701A (en) 2001-07-16
FI20002217L (fi) 2001-07-01
DE60023547D1 (de) 2005-12-01
DE60023547T3 (de) 2019-06-13
EP1242048A1 (de) 2002-09-25
ES2251418T5 (es) 2019-07-19
JP5139615B2 (ja) 2013-02-06
FI20002217A0 (fi) 2000-10-06

Similar Documents

Publication Publication Date Title
DE60023547D1 (de) Partikel zur inhalation
FI20010115A0 (fi) Menetelmä nanopartikkelien valmistamiseksi
JP3388743B2 (ja) 尿素顆粒の製造方法
JPH03500383A (ja) 固体エーロゾル発生器
DE60107862D1 (de) Inhalationspartikel bestehend aus mindestens zwei wirkstoffen
MXPA05007154A (es) Atomizador prepeliculizacion.
WO2004060433A3 (en) Delivery devices
EP0361396B1 (de) Verfahren und Vorrichtung zum Herstellen eines Pulvers von amorphen Partikeln einer keramischen oder metallischen Substanz
TW200706615A (en) Powder coating materials
FI895015A0 (fi) Foerfarande och apparatur foer framstaellning av baerare foer polymerisationskatalysatorer.
FI20002216A0 (fi) Yhdistelmäpartikkelit astman hoitoon
DE50113539D1 (de) VERFAHREN UND VORRICHTUNG ZUR ERZEUGUNG GLOBULÄRER KÖRNER AUS REINST-SILIZIUM MIT DURCHMESSERN VON 50 õm BIS 300 õm UND IHRE VERWENDUNG
SE8702685L (sv) Silikapartiklar, saett foer framstaellnilng av silikapartiklar och anvaending av dessa
CA2230539A1 (en) Apparatus and process for coating a solid particle
DE102018204429A1 (de) Vorrichtung zur förderung und dosierung von pulver und vorrichtung zur herstellung einer schichtstruktur auf einem oberflächenbereich eines bauelements
CN101624195A (zh) 一种硝酸钠球形细颗粒的造粒方法
DE10326231B4 (de) Verfahren zur Herstellung von Enzym-Granulaten
SE461848B (sv) Foerfarande foer atomisering av vaetskor och anordning foer genomfoerande av foerfarandet
Li et al. Aspirin particle formation by electric-field-assisted release of droplets
EP3768870B1 (de) Vorrichtung zur förderung und dosierung von pulver, vorrichtung zur herstellung einer schichtstruktur auf einem oberflächenbereich eines bauelements, flächiges heizelement und verfahren zur herstellung eines flächigen heizelements
EA009533B1 (ru) Способ приготовления гранул мочевины
ITBO970614A1 (it) Metodo ed impianto per la produzione di grani di sale aventi dimensioni granulometriche prefissate.
DE60220536D1 (de) Vorrichtung zur erzeugung von tröpfchenstrahlen eines mit teilchen gefüllten viskosen mediums
ATE245127T1 (de) Verfahren und vorrichtung zur herstellung von aus im wesentlichen sphärischen partikeln gebildeten pulvern
Jayasinghe et al. Electrostatic atomization of chitosan.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties